[ad_1]
LAKE FOREST, IL, April 01, 2024 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) is a pharmaceutical company with comprehensive commercial capabilities that make a difference for patients. Chemical Products, today announced that Chief Financial Officer Ajay Patel will attend the LD Micro Invitational XIV conference in New York on April 9, 2024.
The company will host group presentations at 4:00 PM ET, with individual sessions available throughout the day. Investors interested in meeting with the company can request a meeting on the meeting platform or contact Assertio Investor Relations at mkreps@darrowir.com.
Demo information will be available on the day of the event and can be accessed at https://investor.assertiotx.com. To listen to the demo webcast, please connect to the website link at least 15 minutes before the webcast to ensure sufficient time to download any software you may need.
About assertions
Assertio is a commercial pharmaceutical company delivering differentiated products to patients. We have built our commercial product portfolio by acquiring or licensing approved products. Our comprehensive commercial capabilities include marketing through sales force and impersonal promotional models, go-to-market through payer contracts, and trading and distribution.To learn more about Assertio, visit www.assertiotx.com.
forward-looking statements
Statements in this press release that are not historical facts are forward-looking statements that reflect Assertio’s current expectations, assumptions and estimates regarding future performance and economic conditions. These forward-looking statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements address future events or future performance or operations of Assertio, including risks related to our ability to realize the benefits of our operating model, successfully integrate new assets, explore new business development initiatives, and successfully recruit a successor CEO in a timely manner. All statements other than historical facts may be forward-looking statements, which may be expressed through words such as “anticipate,” “believe,” “could,” “design,” “estimate,” “expect,” “forecast,” “target,” etc. words to identify. , “guidance”, “hint”, “plan”, “possibility”, “goal”, “opportunity”, “prospect”, “plan”, “position”, “potential”, “forecast”, “project”, “anticipate”, “pursue”, “seek”, “should”, “strategy”, “goal”, “will”, “will”, “goal” or other similar expressions convey uncertainty about future events or outcomes are intended to identify forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond Assertio’s control, including Assertio’s Annual Report on Form 10-K and Quarterly Reports on Form 10-K The risks are described in reports on 10-Q filed with the U.S. Securities and Exchange Commission (“SEC”) and other documents Assertio files with the SEC from time to time. Investors and potential investors are urged not to place undue reliance on the forward-looking statements in this press release, which speak only as of the date hereof. Although Assertio may elect to update these forward-looking statements at some point in the future, it expressly disclaims any obligation to update or revise any forward-looking statement contained in this press release, whether as a result of new information or future events, except as may be possible under applicable law. Require.
Investor Contact
Matt Kreps, Managing Director
darrow associates
Cell phone: 214-597-8200
mkreps@darrowir.com
[ad_2]
Source link